OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effects of ayahuasca on the development of ethanol-induced behavioral sensitization and on a post-sensitization treatment in mice
A.J. Oliveira-Lima, Renato Antunes dos Santos, A.W. Hollais, et al.
Physiology & Behavior (2015) Vol. 142, pp. 28-36
Open Access | Times Cited: 83
A.J. Oliveira-Lima, Renato Antunes dos Santos, A.W. Hollais, et al.
Physiology & Behavior (2015) Vol. 142, pp. 28-36
Open Access | Times Cited: 83
Showing 1-25 of 83 citing articles:
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years
Rafael G. dos Santos, Flávia de Lima Osório, José Alexandre S. Crippa, et al.
Therapeutic Advances in Psychopharmacology (2016) Vol. 6, Iss. 3, pp. 193-213
Open Access | Times Cited: 274
Rafael G. dos Santos, Flávia de Lima Osório, José Alexandre S. Crippa, et al.
Therapeutic Advances in Psychopharmacology (2016) Vol. 6, Iss. 3, pp. 193-213
Open Access | Times Cited: 274
Cessation and reduction in alcohol consumption and misuse after psychedelic use
Albert Garcia‐Romeu, Alan K. Davis, Fire Erowid, et al.
Journal of Psychopharmacology (2019) Vol. 33, Iss. 9, pp. 1088-1101
Closed Access | Times Cited: 223
Albert Garcia‐Romeu, Alan K. Davis, Fire Erowid, et al.
Journal of Psychopharmacology (2019) Vol. 33, Iss. 9, pp. 1088-1101
Closed Access | Times Cited: 223
The Therapeutic Potentials of Ayahuasca: Possible Effects against Various Diseases of Civilization
Ede Frecska, Petra Bokor, Michael Winkelman
Frontiers in Pharmacology (2016) Vol. 7
Open Access | Times Cited: 211
Ede Frecska, Petra Bokor, Michael Winkelman
Frontiers in Pharmacology (2016) Vol. 7
Open Access | Times Cited: 211
Classic hallucinogens in the treatment of addictions
Michael P. Bogenschutz, Matthew W. Johnson
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2015) Vol. 64, pp. 250-258
Closed Access | Times Cited: 204
Michael P. Bogenschutz, Matthew W. Johnson
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2015) Vol. 64, pp. 250-258
Closed Access | Times Cited: 204
Ayahuasca: Pharmacology, neuroscience and therapeutic potential
Elisabet Domínguez‐Clavé, Joaquim Soler, Matilde Elices, et al.
Brain Research Bulletin (2016) Vol. 126, pp. 89-101
Closed Access | Times Cited: 181
Elisabet Domínguez‐Clavé, Joaquim Soler, Matilde Elices, et al.
Brain Research Bulletin (2016) Vol. 126, pp. 89-101
Closed Access | Times Cited: 181
The Therapeutic Potential of Psychedelics in Treating Substance Use Disorders: A Review of Clinical Trials
Lavinia Hogea, Dana Cătălina Tabugan, Iuliana Costea, et al.
Medicina (2025) Vol. 61, Iss. 2, pp. 278-278
Open Access | Times Cited: 2
Lavinia Hogea, Dana Cătălina Tabugan, Iuliana Costea, et al.
Medicina (2025) Vol. 61, Iss. 2, pp. 278-278
Open Access | Times Cited: 2
Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness
Jonathan Hamill, Jaime E. C. Hallak, Serdar Dursun, et al.
Current Neuropharmacology (2018) Vol. 17, Iss. 2, pp. 108-128
Open Access | Times Cited: 144
Jonathan Hamill, Jaime E. C. Hallak, Serdar Dursun, et al.
Current Neuropharmacology (2018) Vol. 17, Iss. 2, pp. 108-128
Open Access | Times Cited: 144
The current state of research on ayahuasca: A systematic review of human studies assessing psychiatric symptoms, neuropsychological functioning, and neuroimaging
Rafael G. dos Santos, Fermanda M Balthazar, José Carlos Bouso, et al.
Journal of Psychopharmacology (2016) Vol. 30, Iss. 12, pp. 1230-1247
Closed Access | Times Cited: 112
Rafael G. dos Santos, Fermanda M Balthazar, José Carlos Bouso, et al.
Journal of Psychopharmacology (2016) Vol. 30, Iss. 12, pp. 1230-1247
Closed Access | Times Cited: 112
Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT
Vanja Dakic, Juliana Nascimento, Rafaela Sartore, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 109
Vanja Dakic, Juliana Nascimento, Rafaela Sartore, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 109
Psychological and neuropsychological assessment of regular hoasca users
Paulo César Ribeiro Barbosa, Rick J. Strassman, Dartiu Xavier da Silveira, et al.
Comprehensive Psychiatry (2016) Vol. 71, pp. 95-105
Closed Access | Times Cited: 91
Paulo César Ribeiro Barbosa, Rick J. Strassman, Dartiu Xavier da Silveira, et al.
Comprehensive Psychiatry (2016) Vol. 71, pp. 95-105
Closed Access | Times Cited: 91
Dark Classics in Chemical Neuroscience: N,N-Dimethyltryptamine (DMT)
Lindsay P. Cameron, David E. Olson
ACS Chemical Neuroscience (2018) Vol. 9, Iss. 10, pp. 2344-2357
Closed Access | Times Cited: 89
Lindsay P. Cameron, David E. Olson
ACS Chemical Neuroscience (2018) Vol. 9, Iss. 10, pp. 2344-2357
Closed Access | Times Cited: 89
Effects of Ayahuasca and its Alkaloids on Drug Dependence: A Systematic Literature Review of Quantitative Studies in Animals and Humans
Amanda Amorin Nunes, Rafael G. dos Santos, Flávia de Lima Osório, et al.
Journal of Psychoactive Drugs (2016) Vol. 48, Iss. 3, pp. 195-205
Open Access | Times Cited: 83
Amanda Amorin Nunes, Rafael G. dos Santos, Flávia de Lima Osório, et al.
Journal of Psychoactive Drugs (2016) Vol. 48, Iss. 3, pp. 195-205
Open Access | Times Cited: 83
Assessment of Alcohol and Tobacco Use Disorders Among Religious Users of Ayahuasca
Paulo César Ribeiro Barbosa, Luís Fernando Tófoli, Michael P. Bogenschutz, et al.
Frontiers in Psychiatry (2018) Vol. 9
Open Access | Times Cited: 78
Paulo César Ribeiro Barbosa, Luís Fernando Tófoli, Michael P. Bogenschutz, et al.
Frontiers in Psychiatry (2018) Vol. 9
Open Access | Times Cited: 78
Classic and non‐classic psychedelics for substance use disorder: A review of their historic, past and current research
Fúlvio Rieli Mendes, Cristiane dos Santos Costa, Victor Distefano Wiltenburg, et al.
Addiction Neuroscience (2022) Vol. 3, pp. 100025-100025
Open Access | Times Cited: 33
Fúlvio Rieli Mendes, Cristiane dos Santos Costa, Victor Distefano Wiltenburg, et al.
Addiction Neuroscience (2022) Vol. 3, pp. 100025-100025
Open Access | Times Cited: 33
Classic psychedelics and alcohol use disorders: A systematic review of human and animal studies
Javier Calleja‐Conde, José Á. Morales-García, Víctor Echeverry‐Alzate, et al.
Addiction Biology (2022) Vol. 27, Iss. 6
Open Access | Times Cited: 31
Javier Calleja‐Conde, José Á. Morales-García, Víctor Echeverry‐Alzate, et al.
Addiction Biology (2022) Vol. 27, Iss. 6
Open Access | Times Cited: 31
N,N‐dimethyltryptamine and Amazonian ayahuasca plant medicine
Edward James, Joachim Keppler, Thomas L Robertshaw, et al.
Human Psychopharmacology Clinical and Experimental (2022) Vol. 37, Iss. 3
Open Access | Times Cited: 30
Edward James, Joachim Keppler, Thomas L Robertshaw, et al.
Human Psychopharmacology Clinical and Experimental (2022) Vol. 37, Iss. 3
Open Access | Times Cited: 30
Ayahuasca's therapeutic potential: What we know – and what not
Lucas Oliveira Maia, Dimitri Daldegan‐Bueno, Isabel Wießner, et al.
European Neuropsychopharmacology (2022) Vol. 66, pp. 45-61
Closed Access | Times Cited: 28
Lucas Oliveira Maia, Dimitri Daldegan‐Bueno, Isabel Wießner, et al.
European Neuropsychopharmacology (2022) Vol. 66, pp. 45-61
Closed Access | Times Cited: 28
Toxicity of ayahuasca after 28 days daily exposure and effects on monoamines and brain-derived neurotrophic factor (BDNF) in brain of Wistar rats
Camila Schoueri Colaço, Stefany Sousa Alves, Luciana Marangni Nolli, et al.
Metabolic Brain Disease (2020) Vol. 35, Iss. 5, pp. 739-751
Closed Access | Times Cited: 48
Camila Schoueri Colaço, Stefany Sousa Alves, Luciana Marangni Nolli, et al.
Metabolic Brain Disease (2020) Vol. 35, Iss. 5, pp. 739-751
Closed Access | Times Cited: 48
Ayahuasca: Uses, Phytochemical and Biological Activities
Edgar Antonio Estrella-Parra, Julio César Almanza-Pérez, Francisco Javier Alarcón-Aguilar
Natural Products and Bioprospecting (2019) Vol. 9, Iss. 4, pp. 251-265
Open Access | Times Cited: 47
Edgar Antonio Estrella-Parra, Julio César Almanza-Pérez, Francisco Javier Alarcón-Aguilar
Natural Products and Bioprospecting (2019) Vol. 9, Iss. 4, pp. 251-265
Open Access | Times Cited: 47
Effects of ayahuasca and its alkaloids on substance use disorders: an updated (2016–2020) systematic review of preclinical and human studies
Lucas Silva Rodrigues, Giordano Novak Rossi, Juliana Mendes Rocha, et al.
European Archives of Psychiatry and Clinical Neuroscience (2021) Vol. 272, Iss. 4, pp. 541-556
Closed Access | Times Cited: 38
Lucas Silva Rodrigues, Giordano Novak Rossi, Juliana Mendes Rocha, et al.
European Archives of Psychiatry and Clinical Neuroscience (2021) Vol. 272, Iss. 4, pp. 541-556
Closed Access | Times Cited: 38
A review on β-carboline alkaloids and their distribution in foodstuffs: A class of potential functional components or not?
Zhejun Xie, Ning Cao, Changhong Wang
Food Chemistry (2021) Vol. 348, pp. 129067-129067
Closed Access | Times Cited: 36
Zhejun Xie, Ning Cao, Changhong Wang
Food Chemistry (2021) Vol. 348, pp. 129067-129067
Closed Access | Times Cited: 36
Ayahuasca: A review of historical, pharmacological, and therapeutic aspects
Simon Ruffell, Max Crosland‐Wood, Rob Palmer, et al.
Psychiatry and Clinical Neurosciences Reports (2023) Vol. 2, Iss. 4
Open Access | Times Cited: 14
Simon Ruffell, Max Crosland‐Wood, Rob Palmer, et al.
Psychiatry and Clinical Neurosciences Reports (2023) Vol. 2, Iss. 4
Open Access | Times Cited: 14
Ayahuasca and Its DMT- and β-carbolines – Containing Ingredients Block the Expression of Ethanol-Induced Conditioned Place Preference in Mice: Role of the Treatment Environment
Elisangela Gouveia Cata-Preta, Yasmim A. Serra, Eliseu da Cruz Moreira-Junior, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 41
Elisangela Gouveia Cata-Preta, Yasmim A. Serra, Eliseu da Cruz Moreira-Junior, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 41
Psychoactive Substances of Natural Origin: Toxicological Aspects, Therapeutic Properties and Analysis in Biological Samples
Joana Gonçalves, Ângelo Luís, Eugénia Gallardo, et al.
Molecules (2021) Vol. 26, Iss. 5, pp. 1397-1397
Open Access | Times Cited: 27
Joana Gonçalves, Ângelo Luís, Eugénia Gallardo, et al.
Molecules (2021) Vol. 26, Iss. 5, pp. 1397-1397
Open Access | Times Cited: 27
Role of 5-HT2A receptors in the effects of ayahuasca on ethanol self-administration using a two-bottle choice paradigm in male mice
Yasmim A. Serra, Thaísa Barros-Santos, Alexia Anjos-Santos, et al.
Psychopharmacology (2022) Vol. 239, Iss. 6, pp. 1679-1687
Open Access | Times Cited: 22
Yasmim A. Serra, Thaísa Barros-Santos, Alexia Anjos-Santos, et al.
Psychopharmacology (2022) Vol. 239, Iss. 6, pp. 1679-1687
Open Access | Times Cited: 22
